C's case, a third oral agent could be added, but DPP-4 and SGLT2 are unlikely to get his HbA1c below 7%
Alarmingly, it is estimated that around 1 million people in the UK are living with undiagnosed type 2 diabetes, presenting significant public health and clinical challenges related to delayed diagnosis and management [1]
Understanding your peptide genetic profile alongside your cardiovascular biomarkers can support a more personalized discussion with your provider about GLP-1 eligibility, expected benefits, monitoring frequency, and whether compounded GLP-1 options (semaglutide or tirzepatide) align with your individual health trajectory
Very dark brown skin: 1 capsule daily up to 12 months but at least 6 months
This duo targets joint pain, muscle recovery, and injury repair
When should I consider Ipamorelin over GHRP-6